Marked synergy by vertical inhibition of EGFR signaling in NSCLC spheroids shows SOS1 is a therapeutic target in EGFR-mutated cancer

Drug treatment of 3D cancer spheroids more accurately reflects in vivo therapeutic responses compared to adherent culture studies. In EGFR-mutated lung adenocarcinoma, EGFR-TKIs show enhanced efficacy in spheroid cultures. Simultaneous inhibition of multiple parallel RTKs further enhances EGFR-TKI e...

Descripción completa

Detalles Bibliográficos
Autores principales: Theard, Patricia L, Sheffels, Erin, Sealover, Nancy E, Linke, Amanda J, Pratico, David J, Kortum, Robert L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2020
Materias:
Cancer Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478890/
https://www.ncbi.nlm.nih.gov/pubmed/32897190
http://dx.doi.org/10.7554/eLife.58204

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478890/
https://www.ncbi.nlm.nih.gov/pubmed/32897190
http://dx.doi.org/10.7554/eLife.58204

Ejemplares similares